Tilray medical expands portfolio of medical cannabis products in the uk

Leamington, ontario, june 29, 2022 (globe newswire) -- tilray brands, inc. ("tilray" or the "company") (nasdaq: tlry; tsx: tlry), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, tilray medical, has expanded its medical cannabis offerings in the united kingdom. tilray medical now offers the broadest portfolio of cannabis flower in the uk market today, including a differentiated range of high thc products, cultivated at its eu-gmp-certified facility in portugal.
TLRY Ratings Summary
TLRY Quant Ranking